AI-generated summary. We recommend consulting the bill text for important decisions.

Existing Utah law prohibits pharmaceutical manufacturers from interfering with the 340B drug discount program — a federal program that allows certain safety-net health care providers, like community health centers and rural hospitals, to purchase drugs at significantly reduced prices. This bill updates that law by adding clearer definitions and tightening the list of prohibited manufacturer actions, including barring manufacturers from imposing time limits on when a covered entity can replenish or submit claims for discounted drugs, requiring covered entities to share contract or claims data as a condition of accessing drugs, or interfering with contracts between covered entities and the pharmacies they work with.